Successful therapy of annular elastolytic giant cell granuloma with fumaric acid esters [5]

Dermatology

Volumn 205, Issue 4, 2002, Pages 421-424

  Gutzmer, Ralf ^a   Breuer, Kristine ^a   Kiehl, Peter ^a   Kapp, Alexander ^a   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Annular elastolytic giant cell granuloma; Fumaric acid ester; Granuloma

Indexed keywords

CHLOROQUINE; FUMADERM; FUMARIC ACID DERIVATIVE; STEROID;

AGED; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; FEMALE; GENERAL CONDITION IMPROVEMENT; GIANT CELL GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELBOW; ESTERS; FEMALE; FOLLOW-UP STUDIES; FOREARM; FUMARATES; GRANULOMA ANNULARE; GRANULOMA, GIANT CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TREATMENT OUTCOME;

EID: 0036432886     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066434     Document Type: Letter

References (32)

1. Hanke CW, Bailin PL, Roenigk HH Jr: Annular elastolytic giant cell granuloma: A clinicopathologic study of five cases and a review of similar entities. J Am Acad Dermatol 1979;1:413-421.
2. Dowling GB, Wilson Jones E: Atypical (annular) necrobiosis lipoidica of the face and scalp. Dermatologica 1967;135:11-26.
3. Wilson Jones E: Necrobiosis lipoidica presenting on the face and scalp. Trans St John's Hosp Dermatol Soc 1971;57:202-220.
4. Mehregan AH, Altman J: Miescher's granuloma of the face. Arch Dermatol 1973;107:62-64.
5. O'Brien JP: Actinic granuloma. Arch Dermatol 1975;93:460-466.
6. Hermes B, Haas N, Czarnetzki BM: Annular elastolytic giant cell granuloma with a spontaneous healing tendency (in German). Hautarzt 1995;46:490-493.
7. Kurose N, Nakagawa H, Iozumi K, Nogita T, Furue M, Ishibashi Y: Systemic elastolytic granulomatosis with cutaneous, ocular, lymph nodal, and intestinal involvement: Spectrum of annular elastolytic giant cell granuloma and sarcoidosis. J Am Acad Dermatol 1992;26:359-363.
8. Ishibashi A, Yokoyama A, Hirano K: Annular elastolytic giant cell granuloma occurring in covered areas. Dermatologica 1987;174:293-297.
9. Muramatsu T, Shirai T, Yamashina Y, Sakamoto K: Annular elastolytic giant cell granuloma: An unusual case with lesions arising in non-sun-exposed areas. J Dermatol 1987;14:54-58.
10. Revenga F, Rovira I, Pimentel J, Alejo M: Annular elastolytic giant cell granuloma - Actinic granuloma? Clin Exp Dermatol 1996;21:51-53.
11. Tsutsui K, Hirone T, Kubo K, Matsui Y: Annular elastolytic giant cell granuloma: Response to cyclosporin A. J Dermatol 1994;21:426-429.
12. Boneschi V, Brambilla L, Fossati S, Parini F, Alessi E: Annular elastolytic giant cell granuloma. Am J Dermatopathol 1988;10:224-228.
13. Lee YS, Vijayasingam S, Chan HL: Photosensitive annular elastolytic giant cell granuloma with cutaneous amyloidosis. Am J Dermatopathol 1989;11:443-450.
14. Ozkaya-Bayazit E, Buyukbabani N, Baykal C, Ozturk A, Okcu M, Soyer HP: Annular elastolytic giant cell granuloma: Sparing of a burn scar and successful treatment with chloroquine. Br J Dermatol 1999;140:525-530.
15. Vehring KH, Bonsmann G, Brocker EB, Hamm H: Annular elastolytic giant cell granuloma - Differential diagnosis of cutaneous granulomatosis (in German). Hautarzt 1991;42:391-395.
16. Igawa K, Maruyama R, Katayama I, Nishioka K: Anti-oxidative therapy with oral dapsone improved HCV antibody positive annular elastolytic giant cell granuloma. J Dermatol 1997;24:328-331.
17. Hohenleutner S, Wlotzke U, Landthaler M, Stolz W: Elastolysis of the mid-dermis and annular elastolytic giant cell granuloma: Different stages in the clinical spectrum of dermal elastolysis? Case report and review of the literature (in German). Hautarzt 1997;48:45-50.
18. Mrowietz U, Christophers E, Altmeyer P: Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol 1999;141:424-429.
19. Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G, et al: Antipsoriatic effect of fumaric acid derivatives: Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994;30:977-981.
20. Mrowietz U, Christophers E, Altmeyer P: Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study. German Multicentre Study. Br J Dermatol 1998;138:456-460.
21. Altmeyer P, Nuchel C: Systemic treatment of psoriasis by fumaric acid derivatives (in French). Ann Dermatol Vénéréol 1996;123:838-841.
22. Petres J, Kalkoff KW, Baron D, Geiger R, Kunick I: The effect of fumaric acid monoethylester on the synthesis of nucleic acids and proteins of PHA-stimulated human lymphocytes (author's transl). Arch Dermatol Forsch 1975;251:295-300.
23. Bacharach-Buhles M, Pawlak FM, Matthes U, Joshi RK, Altmeyer P: Fumaric acid esters (FAEs) suppress CD15- and ODP4-positive cells in psoriasis. Acta Derm Venereol Suppl 1994;186:79-82.
24. Hoxtermann S, Nuchel C, Altmeyer P: Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 1998;196:223-230.
25. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw-Kraan T, Ottenhoff TH, Nibbering PH: Selective stimulation of T helper 2 cytokine responses by the anti- psoriasis agent monomethylfumarate. Eur J Immunol 1996;26:2067-2074.
26. Ockenfels HM, Schultewolter T, Ockenfels G, Funk R, Goos M: The anti-psoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998;139:390-395.
27. Asadullah K, Schmid H, Friedrich M, Randow F, Volk HD, Sterry W, Docke WD: Influence of monomethylfumarate on monocytic cytokine formation - Explanation for adverse and therapeutic effects in psoriasis? Arch Dermatol Res 1997;289:623-630.
28. Nestle FO, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells in psoriasis: Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994;94:202-209.
29. Fayyazi A, Schweyer S, Eichmeyer B, Herms J, Hemmerlein B, Radzun HJ, Berger H: Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 2000;292:384-390.
30. Bergeron A, Bonay M, Kambouchner M, Lecossier D, Riquet M, Soler P, Hance A, Tazi A: Cytokine patterns in tuberculous and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response. J Immunol 1997;159:3034-3043.
31. Kakazu T, Hara J, Matsumoto T, Nakamura S, Oshitani N, Arakawa T, Kitano A, Nakatani K, Kinjo F, Kuroki T: Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am J Gastroenterol 1999;94:2149-2155.
32. Schulze-Dirks A, Petzoldt D: Granuloma annulare disseminatum: Successful therapy with fumaric acid ester (in German). Hautarzt 2001;52:228-230.